BioPharma Credit PLC (BOPCF PINK) stock market data APIs
$0.9099
0(0%)
as of September 9, 2025
Try our APIs with
free plan!
BioPharma Credit PLC Financial Data Overview
Price chart is built with
Anychart
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Prev. Close
0.9099
Open
0.9099
High
0.9119
Low
0.905
52 wk Range
0.7416-0.9362
Market Cap
1 161 M
P/E Ratio
13.3774
Shares Outstanding
914 M
Revenue
150 M
EPS
0.0161
Dividends (Yield)
0.0824
Beta
0.103
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BioPharma Credit PLC data using free add-ons & libraries
Get BioPharma Credit PLC Fundamental Data
BioPharma Credit PLC Fundamental data includes:
- Net Revenue: 150 M
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BioPharma Credit PLC News
New
Taylor Wimpey to be kicked out of FTSE 100 and Metlen added to blue-chip index
Housebuilder Taylor Wimpey (TW.L) is set to be kicked out of the FTSE 100 (^FTSE) in the latest quarterly reshuffle, while energy group Metlen Energy & Metals (MTLN.L) is due to join the blue-chip ind...
BioPharma Credit PLC (LON:BPCR) Looks Interesting, And It's About To Pay A Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that BioPharma Credit PLC (LON:BPCR) is about to go ex-dividend i...
Investing in BioPharma Credit (LON:BPCR) five years ago would have delivered you a 19% gain
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But even in a market-beating portfolio, some stocks will lag the market. While the BioPharma Credi...
BioPharma Credit PLC (LON:BPCR) Passed Our Checks, And It's About To Pay A US$0.018 Dividend
Readers hoping to buy BioPharma Credit PLC (LON:BPCR) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually set to be one b...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
